Medical Devices Series A Investors & VC Firms
1145 firms in this list, with a median first check of $500K. 237 of them lead rounds. Generated from verified public data and updated continuously.
ODYSSEE VENTURE
ParisSeed–Late Stage$1.1M – $11M
1 person
Redhills Ventures LLC
Las VegasSeed–Late Stage$125K – $7M
3 people
53 Stations
BostonSeed–Series A
4 people
ACORN BIOVENTURES
New YorkSeed–Late Stage
4 people
Cape Fear BioCapital
DurhamPre-Seed–Series B
3 people
Day One Capital
BudapestPre-Seed–Series A$330K – $2.2M
the Untitled Ventures
LuxembourgPre-Seed–Series A
3 people
Chiesi Ventures
BostonSeed–Series A$5M
2 people
Digital Health Ventures
BerlinSeed–Series A
2 people
Leafy Tunnel
LondonSeed–Series A
2 people
NCL Technology Ventures Ltd.
LondonSeed–Series A
2 people
Bluebird Ventures
Palo AltoSeed–Series B
1 person
Air Liquide Venture Capital (ALIAD)
ParisSeed–Growth
Trinity Innovation Bioventure Singapore
SingaporeSeed–Late Stage
3 people
WakeUp Capital
DublinPre-Seed–Series A
WRF Capital
SeattlePre-Seed–Series B$100K – $2M
Israel Biotech Fund
RehovotSeed–Series A
5 people
Redesign Health
New YorkSeed–Late Stage
2 people
City Hill Ventures
San DiegoSeed–Series A$100K – $20M
1 person
Fir Capital
Nova LimaSeed–Growth$100K – $5M
1 person
HealthCare Ventures, LLC
CambridgeSeries A–Late Stage$1M – $20M
1 person
Israel Innovation Authority
JerusalemPre-Seed–Growth$140K – $5M
1 person
Empirical Ventures
LondonPre-Seed–Series A
4 people
Majuven
SingaporeSeed–Late Stage
4 people
Related lists
Series A Investors & VC Firms (7875)Series A Investors & VC Firms in United States (3337)SaaS Series A Investors & VC Firms (2667)AI & Machine Learning Series A Investors & VC Firms (2343)Enterprise Software Series A Investors & VC Firms (2324)Fintech Series A Investors & VC Firms (2239)Healthtech Series A Investors & VC Firms (2210)Series A Investors & VC Firms in Global (2163)Consumer Series A Investors & VC Firms (1652)Series A Investors & VC Firms in Europe (1634)
Data sourced from public filings and firms' own websites — see our methodology.












